ATYR
Price
$5.83
Change
+$0.28 (+5.05%)
Updated
Jul 25 closing price
Capitalization
518.9M
18 days until earnings call
DRUG
Price
$35.45
Change
+$3.47 (+10.85%)
Updated
Jul 25 closing price
Capitalization
250.45M
Interact to see
Advertisement

ATYR vs DRUG

Header iconATYR vs DRUG Comparison
Open Charts ATYR vs DRUGBanner chart's image
aTyr Pharma
Price$5.83
Change+$0.28 (+5.05%)
Volume$3.81M
Capitalization518.9M
Bright Minds Biosciences
Price$35.45
Change+$3.47 (+10.85%)
Volume$96.52K
Capitalization250.45M
ATYR vs DRUG Comparison Chart in %
Loading...
ATYR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DRUG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ATYR vs. DRUG commentary
Jul 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATYR is a Hold and DRUG is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 26, 2025
Stock price -- (ATYR: $5.83 vs. DRUG: $35.46)
Brand notoriety: ATYR and DRUG are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATYR: 99% vs. DRUG: 225%
Market capitalization -- ATYR: $518.9M vs. DRUG: $250.45M
ATYR [@Biotechnology] is valued at $518.9M. DRUG’s [@Biotechnology] market capitalization is $250.45M. The market cap for tickers in the [@Biotechnology] industry ranges from $313.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATYR’s FA Score shows that 0 FA rating(s) are green whileDRUG’s FA Score has 0 green FA rating(s).

  • ATYR’s FA Score: 0 green, 5 red.
  • DRUG’s FA Score: 0 green, 5 red.
According to our system of comparison, DRUG is a better buy in the long-term than ATYR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATYR’s TA Score shows that 3 TA indicator(s) are bullish while DRUG’s TA Score has 4 bullish TA indicator(s).

  • ATYR’s TA Score: 3 bullish, 5 bearish.
  • DRUG’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, DRUG is a better buy in the short-term than ATYR.

Price Growth

ATYR (@Biotechnology) experienced а -2.67% price change this week, while DRUG (@Biotechnology) price change was +35.53% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.58%. For the same industry, the average monthly price growth was +17.35%, and the average quarterly price growth was +27.29%.

Reported Earning Dates

ATYR is expected to report earnings on Nov 06, 2025.

DRUG is expected to report earnings on May 15, 2025.

Industries' Descriptions

@Biotechnology (+7.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ATYR($519M) has a higher market cap than DRUG($250M). ATYR YTD gains are higher at: 61.050 vs. DRUG (-1.569). DRUG has higher annual earnings (EBITDA): -2.67M vs. ATYR (-65.9M). ATYR has more cash in the bank: 76.3M vs. DRUG (57.9M). DRUG has less debt than ATYR: DRUG (183K) vs ATYR (13M). ATYR (0) and DRUG (0) have equivalent revenues.
ATYRDRUGATYR / DRUG
Capitalization519M250M208%
EBITDA-65.9M-2.67M2,467%
Gain YTD61.050-1.569-3,892%
P/E RatioN/AN/A-
Revenue00-
Total Cash76.3M57.9M132%
Total Debt13M183K7,104%
FUNDAMENTALS RATINGS
ATYR: Fundamental Ratings
ATYR
OUTLOOK RATING
1..100
74
VALUATION
overvalued / fair valued / undervalued
1..100
82
Overvalued
PROFIT vs RISK RATING
1..100
88
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
36
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
11

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ATYRDRUG
RSI
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
71%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
82%
Bearish Trend 1 day ago
74%
Momentum
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
88%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
85%
Bullish Trend 1 day ago
85%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 11 days ago
79%
Bullish Trend 1 day ago
85%
Declines
ODDS (%)
Bearish Trend 5 days ago
84%
Bearish Trend 16 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
73%
Bearish Trend 1 day ago
84%
Aroon
ODDS (%)
Bullish Trend 4 days ago
87%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ATYR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DRUG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
HCOW24.000.06
+0.25%
Amplify COWS Covered Call ETF
BCLO49.920.03
+0.07%
iShares BBB-B CLO Active ETF
IDVO34.55-0.08
-0.23%
Amplify CWP International Enh Div IncETF
BCI21.09-0.20
-0.94%
abrdn Blmb AllCmdStrK1Fr ETF
RIGS22.96-0.32
-1.39%
RiverFront Strategic Income ETF

ATYR and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATYR has been loosely correlated with MGTX. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if ATYR jumps, then MGTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATYR
1D Price
Change %
ATYR100%
+4.95%
MGTX - ATYR
43%
Loosely correlated
+0.72%
RZLT - ATYR
41%
Loosely correlated
+7.33%
SLDB - ATYR
41%
Loosely correlated
+4.79%
IDYA - ATYR
41%
Loosely correlated
-1.33%
AURA - ATYR
40%
Loosely correlated
+2.41%
More